XHKG
8513
Market cap3mUSD
Oct 23, Last price
0.38HKD
1D
22.58%
1Q
18.75%
IPO
-54.76%
Name
IAG Holdings Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
IAG Holdings Limited functions as an investment holding company, primarily focusing on the manufacturing and sale of injection-molded plastic components for single-use medical devices. The company also provides specialized tooling services, involving the fabrication of molds critical for the injection molding process. Its plastic products encompass both individual parts and assembled sub-components, designed for a variety of medical applications such as respiratory, dialysis, blood bag, drug delivery, and diagnostic equipment. Major clients include prominent multinational medical device corporations based in the United States, Europe, and Japan.
Key people
Executive Chairman of the Board, Chief Executive Officer · since 2017
Hong Kiew Ng
Compliance Officer, Head - Finance and Administration, Executive Director · since 2017
Jiang Yuan Yang
Executive Director · since 2019
Quee Seng Wong
Toolroom Manager of Inzign · since 2016
Yung Kwong Hon
Joint Company Secretary · since 2019
Koon Chuan Tay
Non-Executive Director · since 2017
Non-Executive Independent Director · since 2017
Yew Bock Tan
Independent Non-Executive Director · since 2017
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||